Healthcare Reimbursement Market 2028 By Claim, Payers, Service Provider and Geography | The Insight Partners

report image

Healthcare Reimbursement Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Claim (Underpaid, Full Paid); Payers (Private Payers, Public Payers); Service Provider (Physician office, Hospitals, Diagnostic Laboratories, Others) and Geography

Report Code: TIPRE00003081 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming


The payment that hospitals, diagnostic centers, doctors, and other health care professionals receive for providing medical services to individuals is known as healthcare reimbursement. Frequently, a government payer or health insurer pays for a person's medical bills in part or in full. The person might claim reimbursement money from the health insurance provider depending on the health insurance plan opted. Payment is typically made after receiving medical services, which is why it is referred to as reimbursement. Advancement in the of electronic medical record (EMR) technology for monitoring patient responsiveness, provider practice, and functioning of health care organizations have the capacity to not only strengthen the accuracy and efficiency of reimbursement policies but also to improve the standard of medical care.


The "Global Healthcare Reimbursement Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the healthcare reimbursement market with detailed market segmentation by claim, payers and service provider. The report provides key statistics on the market status of the leading healthcare reimbursement market players and offers key trends and opportunities in the market.


  •   Based on claim the market is segmented as, underpaid and full paid.
  •   Based on payers the market is segmenetd as, provate payers and public payers.
  •   Based on service provider the market is segmenetd as, physician office, hospitals, diagnostic laboratories and others.



  •   Growing prevalence of chronic diseases and prolonged hospital stays which ultimately puts a burden of expenses on patients is the key driver for the market growth.
  •   Rising demand for reimbursement polices which covers all the medical expense of entire family.
  •   Increasing healthcare expenditures and improvements in healthcare facilities.


  •   However, issues such as poor quality of care provided to patients, fraudulant activities associated with reimbursement policies are likely to restrain market growth.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The healthcare reimbursement market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the healthcare reimbursement market in these regions.


COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.


The report covers key developments in the healthcare reimbursement market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from healthcare reimbursement market are anticipated to lucrative growth opportunities in the future with the rising demand for healthcare reimbursement in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the healthcare reimbursement market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   UnitedHealthcare
  •   Aviva
  •   Aetna Inc.
  •   Care Health Insurance
  •   WellCare Health Plans, Inc.
  •   AgileHealthInsurance
  •   Blue Cross and Blue Shield of North Carolina
  •   Allianz Care
  •   Max Bupa Health Insurance Company Ltd
  •   Reliance Nippon Life Insurance Company Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies

1. UnitedHealthcare
2. Aviva
3. Aetna Inc.
4. Care Health Insurance
5. WellCare Health Plans, Inc.
6. AgileHealthInsurance
7. Blue Cross and Blue Shield of North Carolina
8. Allianz Care
9. Max Bupa Health Insurance Company Ltd
10. Reliance Nippon Life Insurance Company Limited
11. BNP Paribas
12. Centene Corporation
13. Medica
14. Life Insurance Corporation of India
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market


Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount